Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZVE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,433
Award facts
- Contract value 100% obligated
- $13,433.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,433.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This non-set-aside contract was awarded on January 23, 2026, with an ultimate completion date of January 26, 2026, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and Defense Health Agency. The company competes on a full and open basis for federal procurements and has demonstrated capability across a diverse portfolio of pharmaceutical products spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical devices. This specific delivery order for Repatha, a prescription medication used in cardiovascular treatment, exemplifies the company's role in supporting military healthcare supply chain requirements through the DLA's pharmaceutical procurement processes.
Quick answers
Who was awarded contract SPE2DR26F4ZVE?
SPE2DR26F4ZVE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F4ZVE worth?
The government has obligated $13,433 on SPE2DR26F4ZVE.
Is contract SPE2DR26F4ZVE an order under another contract?
Yes. SPE2DR26F4ZVE is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZVE competed?
The extent of competition for SPE2DR26F4ZVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award